|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development |
| 1. |
Synaptic Pharmaceutical Corp.
|
|
|
Applies human receptor-targeted drug design technology to discover and clone genes and to design G protein-coupled receptor agonist and antagonists. Based in Paramus, New Jersey. (Nasdaq: SNAP)
|
| 2. |
BioSphings AG.
|
|
|
Development and marketing of products to treat viral infections, cancer and autoimmune diseases. Features product pipeline and company details. Frankfurt, Germany.
|
| 3. |
Xencor, Inc.
|
|
|
Technology for MHC epitope removal, glycosylation to optimize pharmacokinetics, masking immune recognition sites and engineering monoclonal antibodies. Includes discovery programs, partnering opportunities in Monrovia, California. ImmunoPDAa?? Technology Product Sheet Caltech spin-off developing proteomic technologies to accelerate drug discovery.
|
| 4. |
Trophogen, Inc
|
|
|
Development of superactive hormones and growth factors for therapeutic applications. Based in Rockville, Maryland, USA.
|
| 5. |
Archemix Corp.
|
|
|
Company developing therapeutics of aptamers, for the prevention and treatment of chronic and acute disease. Includes overview of technology and commercial potential, careers and contacts in Cambridge, Massachusetts.
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
